Javascript must be enabled to continue!
Abstract MP02: Proprotein Convertase Subtilisin/kexin Type 6 (PCSK6) Is Involved In Regulation Of Vasculogenesis
View through CrossRef
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia. We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels.
Hypothesis:
We hypothesize that a) the processes of vasculogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and b) that PCSK6 plays a common role in vascular remodeling.
Methods:
Association between SNPs near the PCSK6 gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium. Data from the FinnGen consortium (Release 3) were queried to explore the PCSK6 SNPs associated with specific disease phenotypes. Morpholino technology was used for Pcsk6 knockdown in zebrafish, coupled with vascular phenotype studies.
Pcsk6-/-
mice were used to study the expression of vasculogenesis related genes as well as vascular morphology.
Results:
Rs7178801 and rs11639051 in the
PCSK6
gene were found to relate to plasma PDGFB and VEGFD levels, while rs45482895 associated with diabetic retinopathy and disorders of the choroid and retina in humans. Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels, cerebral and myocardial haemorrhage, atrial dilatation and pericardial oedema. Gene expression levels of vasculogenesis related genes, i.e. Vegfa, Vegfb, Angpt1 and Tgfb2 were altered in the heart, liver and adipose tissue in
Pcsk6-/-
mice. In the retinas of
Pcsk6-/-
mice, Pdgfb was significantly downregulated compared to controls. Staining of the retinal vasculature showed that superficial retinal vasculature had a lower number of branching points and vessel width, while deep retinal vasculature covered a significantly smaller area in
Pcsk6-/-
Conclusions:
Here, we show that variants in the
PCSK6
gene associate with growth factors implicated in vasculogenesis and retinopathy. Lack of
Pcsk6
in mice and zebrafish led to vascular patterning defects. Further studies will aim to elucidate the mechanisms by which PCSK6 regulates vasculogenesis in homeostatic and pathological conditions
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract MP02: Proprotein Convertase Subtilisin/kexin Type 6 (PCSK6) Is Involved In Regulation Of Vasculogenesis
Description:
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia.
We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels.
Hypothesis:
We hypothesize that a) the processes of vasculogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and b) that PCSK6 plays a common role in vascular remodeling.
Methods:
Association between SNPs near the PCSK6 gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium.
Data from the FinnGen consortium (Release 3) were queried to explore the PCSK6 SNPs associated with specific disease phenotypes.
Morpholino technology was used for Pcsk6 knockdown in zebrafish, coupled with vascular phenotype studies.
Pcsk6-/-
mice were used to study the expression of vasculogenesis related genes as well as vascular morphology.
Results:
Rs7178801 and rs11639051 in the
PCSK6
gene were found to relate to plasma PDGFB and VEGFD levels, while rs45482895 associated with diabetic retinopathy and disorders of the choroid and retina in humans.
Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels, cerebral and myocardial haemorrhage, atrial dilatation and pericardial oedema.
Gene expression levels of vasculogenesis related genes, i.
e.
Vegfa, Vegfb, Angpt1 and Tgfb2 were altered in the heart, liver and adipose tissue in
Pcsk6-/-
mice.
In the retinas of
Pcsk6-/-
mice, Pdgfb was significantly downregulated compared to controls.
Staining of the retinal vasculature showed that superficial retinal vasculature had a lower number of branching points and vessel width, while deep retinal vasculature covered a significantly smaller area in
Pcsk6-/-
Conclusions:
Here, we show that variants in the
PCSK6
gene associate with growth factors implicated in vasculogenesis and retinopathy.
Lack of
Pcsk6
in mice and zebrafish led to vascular patterning defects.
Further studies will aim to elucidate the mechanisms by which PCSK6 regulates vasculogenesis in homeostatic and pathological conditions.
Related Results
Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation
Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while...
Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia
Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia
Abstract
Aims
Familial hypercholesterolemia patients are characterized by early onset of coronary artery calcification and ather...
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein convertase subtilisin/kexin 6 (PCSK6) is a secreted serine protease expressed in most major organs, where it cleaves a wide range of growth factors, signaling molecules,...
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
The selective pressures challenging the human population leave genetic signatures. This study was designed to detect positive and balancing selection on the proprotein convertase s...
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Background:
The focus of this study was the selection of a single chain variable fragment
antibody (scFv) against subtilisin BRC, a fibrinolytic enzyme using phage display, and to...
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Abstract
Aims
Proprotein convertase subtilisin/kexin type-9 (PCSK9), a molecular determinant of low-density lipoprotein (LDL) re...
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
Proprotein convertase subtilisin/Kexin type 9 (PCSK9) is a proteolytic enzyme that indirectly regulates serum LDL cholesterol by destroying LDL receptors. In clinical studies, the ...
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech
Helobdella
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech
Helobdella
Abstract
Intercellular communication is quintessential for multicellularity and often mediated by secreted peptide ligands. In Metazoa, proprotei...

